NASDAQ:CYRXCryoPort Stock Price, Forecast & News

CryoPort's stock was trading at $16.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CYRX shares have increased by 95.7% and is now trading at $32.53.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CryoPort.

CryoPort is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for CryoPort.

CryoPort Inc (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, August, 6th. The consumer goods maker reported ($0.15) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.04. The consumer goods maker had revenue of $9.39 million for the quarter, compared to the consensus estimate of $8.93 million. CryoPort had a negative net margin of 60.97% and a negative return on equity of 19.09%. The firm's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.08) EPS.
View CryoPort's earnings history.

5 brokers have issued twelve-month price targets for CryoPort's shares. Their forecasts range from $21.00 to $40.00. On average, they anticipate CryoPort's share price to reach $29.67 in the next year. This suggests that the stock has a possible downside of 8.8%.
View analysts' price targets for CryoPort.

News stories about CYRX stock have been trending extremely negative on Thursday, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a news sentiment score of -4.1 on InfoTrie's scale. They also assigned media coverage about the consumer goods maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about CryoPort.

CryoPort saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 8,800,000 shares, an increase of 14.0% from the December 31st total of 7,720,000 shares. Based on an average daily volume of 422,300 shares, the days-to-cover ratio is currently 20.8 days.
View CryoPort's Short Interest.

Some companies that are related to CryoPort include Brink's (BCO), Hub Group (HUBG), Forward Air (FWRD), Echo Global Logistics (ECHO), Roadrunner Transportation Systems (RRTS) and Sino-Global Shipping America (SINO).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Advanced Micro Devices (AMD), Gilead Sciences (GILD), NVIDIA (NVDA), Micron Technology (MU), Taiwan Semiconductor Mfg. (TSM), Vertex Pharmaceuticals (VRTX), QUALCOMM (QCOM), Enterprise Products Partners (EPD), AbbVie (ABBV) and Square (SQ).

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

CryoPort's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.68%), TimesSquare Capital Management LLC (1.99%), GW&K Investment Management LLC (1.79%), Granite Investment Partners LLC (0.99%), Columbus Circle Investors (0.78%) and Taylor Wealth Management Partners (0.63%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for CryoPort.

CYRX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., TimesSquare Capital Management LLC, Creative Planning, Essex Investment Management Co. LLC, Taylor Wealth Management Partners, Penbrook Management LLC, Genesee Capital Advisors LLC, and Columbus Circle Investors. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for CryoPort.

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC, SG Americas Securities LLC, Great Lakes Advisors LLC, Bullseye Asset Management LLC, Braun Stacey Associates Inc., EAM Investors LLC, Bank of New York Mellon Corp, and New York State Common Retirement Fund.
View insider buying and selling activity for CryoPort.

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CYRX stock can currently be purchased for approximately $32.53.

CryoPort has a market capitalization of $1.24 billion and generates $33.94 million in revenue each year. The consumer goods maker earns $-18,330,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

The official website for CryoPort is www.cryoport.com.

CryoPort's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]